Table 1.
Effects of addictive drugs on proliferation, differentiation and survival of adult NSPCs
| Drugs | Organism | Paradigm | Effects | References | ||
|---|---|---|---|---|---|---|
| Proliferation | Neuronal differentiation | Survival | ||||
| Morphine and heroin | Rat | In vivo, acute | – | [36] | ||
| In vivo, chronic | ↓ | ↓ | ||||
| Morphine | Mouse | In vivo, chronic | ↓ | [45] | ||
| Morphine | Mouse | In vivo, chronic | ↓ | [69] | ||
| Buprenorphine | Mouse | In vitro, chronic | ↓ | ↑ | [75] | |
| Morphine | Rat | In vivo, chronic | ↓ | ↓ | [76] | |
| In vivo, withdrawal | ↑ | |||||
| Morphine | Mouse | In vivo, acute | – | [77] | ||
| In vivo, chronic | ↓ | |||||
| Morphine | Mouse | In vitro, chronic | ↓ | ↓ | [78] | |
| Opioid receptor antagonists | Rat | In vitro, chronic | ↓ | ↑ | [79] | |
| Morphine | Mouse | In vitro, chronic | ↑ | ↓ | – | [23, 51] |
| In vivo, chronic | ↓ | |||||
| Fentanyl | Mouse | In vitro, chronic | ↑ | – | ||
| Opioids | Rat | In vitro, chronic | ↑ | [84] | ||
| Cocaine | Rat | In vivo, chronic | ↓ | [22] | ||
| In vivo, withdrawal | ↑ | ↑ | ||||
| Cocaine | Rat | In vivo, acute | – | [40, 58] | ||
| In vivo, chronic | ↓ | – | ||||
| Cocaine | Rat | In vivo, acute | ↓ | [91] | ||
| In vivo, chronic | ↓ | – | ||||
| Cocaine | Human | In vivo, chronic | ↓ | [92] | ||
| Cocaine | Rat | In vivo, acute | – | – | [93] | |
| In vivo, chronic | ↓ | – | ||||
| In vivo, withdrawal | ↓ | ↓ | ||||
| Cocaine | Rat | In vivo, withdrawal | ↓ | [94] | ||
| Cocaine | Rat | In vitro, chronic | ↓ | [95] | ||
| AEA | Rat | In vitro and in vivo, chronic | ↓ | [43] | ||
| Cannabidiol | Mouse | In vivo, chronic | ↓ | ↑ | [66] | |
| Δ9-THC | Mouse | In vivo, chronic | – | – | [66, 67] | |
| HU210 | Rat | In vivo, chronic | – | – | [68] | |
| CB2 agonists | Mouse | In vitro and in vivo, chronic | ↑ | [71] | ||
| HU210 and AEA | Rat | In vitro and in vivo, chronic | ↑ | ↑ | – | [104] |
| Endocannabinoids | Rat | In vitro and in vivo, chronic | ↓ | [106] | ||
| Cannabichromene | Mouse | In vitro, chronic | ↑ | [107] | ||
| WIN 55,212-2 | Rat | In vivo, chronic | – | [108] | ||
| Endocannabinoids | Mouse | In vitro and in vivo, chronic | ↑ | [109] | ||
| Methamphetamine | Rat | In vivo, acute | ↑ | ↑ | [21] | |
| Methamphetamine | Gerbil | In vivo, chronic | ↓ | [38] | ||
| Methamphetamine | Rat | In vitro, chronic | ↓ | [39] | ||
| In vivo, chronic | ↓ | ↓ | ↓ | |||
| Methamphetamine | Rat | In vivo, chronic | ↓ | [62] | ||
| In vivo, withdrawal | ↑ | ↑ | ||||
| Amphetamine | Rat | In vivo, acute | – | [110] | ||
| Amphetamine | Rat | In vivo, chronic | – | – | [111] | |
| In vivo, withdrawal | ||||||
| Amphetamine | Mouse | In vivo, chronic | – | ↑ | ↑ | [112] |
| Methamphetamine | Rat | In vitro, chronic | ↓ | – | ↓ | [113] |
| Nicotine | Rat | In vivo, chronic | ↓ | [61] | ||
| Nicotine | Rat | In vivo, chronic | ↑ | [63] | ||
| Nicotine | Rat | In vivo, chronic | ↓ | ↓ | [114] | |
| Nicotine | Rat | In vivo, acute | – | [115] | ||
| Nicotine | Rat | In vivo, chronic | ↓ | ↓ | [116] | |
| Alcohol | Mouse | In vivo, chronic | ↓ | ↓ | [64] | |
| Alcohol | Rat | In vivo, acute | ↓ | [70] | ||
| In vivo, chronic | ↓ | ↓ | ||||
| Alcohol | Rat | In vivo, chronic | ↓ | [108] | ||
| Alcohol | Rat | In vivo, chronic | ↓ | [119] | ||
| Alcohol | Rat | In vivo, chronic | ↓ | [120] | ||
| In vivo, withdrawal | ↑ | |||||
| Alcohol | Rat | In vivo, chronic | ↑ | [121] | ||
| Alcohol | Rat | In vivo, chronic | ↓ | [122] | ||
| Alcohol | Rat | In vivo, chronic | ↓ | ↓ | [123] | |
| Alcohol | Rat | In vivo, acute | ↓ | ↓ | [124] | |
| Alcohol | Rat | In vivo, chronic | ↓ | [125] | ||
| Alcohol | Mouse | In vivo, chronic | ↓ | [126] | ||
| Alcohol | Rat | In vivo, chronic | ↓ | [127] | ||
| MDMA | Rat | In vivo, chronic | ↓ | [127] | ||
| MDMA | Mouse | In vivo, chronic | ↓ | [129] | ||
| Methylphenidate | Rat | In vivo, chronic | – | [130] | ||
| In vivo, withdrawal | ↓ | |||||
–, no significant change; ↑, up-regulation; ↓, down-regulation